Sales growth was strong for pain drug Lyrica and cancer drug Sutent. Sales declined for anti-hypertension drug Norvasc and smoking-cessation treatment ...
In the fourth quarter, sales of prescription drugs and vaccines hit $14.61 billion. Pfizer's "diversified" division, which sells animal, consumer health and ...
These representatives would market Pfizer vaccines, anti-cancer drugs, anti-cholesterol medicine Lipitor, anti-hypertension drug Norvasc and antibiotic ...
Lipitor sales edged up just 1 percent to $3.18 billion in the quarter and blockbuster blood pressure drug Norvasc, which is steadily losing sales to generic ...
Email this story